News

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Hosted on MSN27d
Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms
Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.
Asian News International on MSN2d
Weight loss drug Mounjaro shown more effective than Wegovy, claims Pharma company
Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating ...
BioSpace16h
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...
Hosted on MSN27d
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%
needle-free alternative in the booming weight loss and diabetes market. Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage ...
STAT6d
Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...